The Journal of Allergy and Clinical Immunology
Volume 119, Issue 3 , Pages 687-696, March 2007

TNF polymorphism and bronchoalveolar lavage cell TNF-α levels in chronic beryllium disease and beryllium sensitization

  • Hiroe Sato, MD, PhD

      Affiliations

    • From the Robert H. Hollis Laboratory of Environmental and Occupational Health, Division of Environmental and Occupational Health Sciences, Department of Medicine, National Jewish Medical and Research Center, Denver
  • ,
  • Lori Silveira, MS

      Affiliations

    • From the Robert H. Hollis Laboratory of Environmental and Occupational Health, Division of Environmental and Occupational Health Sciences, Department of Medicine, National Jewish Medical and Research Center, Denver
  • ,
  • Tasha Fingerlin, PhD

      Affiliations

    • Department of Preventive Medicine and Biometrics
  • ,
  • Karen Dockstader, BS

      Affiliations

    • From the Robert H. Hollis Laboratory of Environmental and Occupational Health, Division of Environmental and Occupational Health Sciences, Department of Medicine, National Jewish Medical and Research Center, Denver
  • ,
  • May Gillespie, BS

      Affiliations

    • From the Robert H. Hollis Laboratory of Environmental and Occupational Health, Division of Environmental and Occupational Health Sciences, Department of Medicine, National Jewish Medical and Research Center, Denver
  • ,
  • Anna L. Lagan, PhD

      Affiliations

    • Clinical Genomic Group, Royal Brompton Hospital and National Heart Lung Institute, Imperial College of Science, Technology and Medicine, London
  • ,
  • Penny Lympany, PhD

      Affiliations

    • Clinical Genomic Group, Royal Brompton Hospital and National Heart Lung Institute, Imperial College of Science, Technology and Medicine, London
  • ,
  • Richard T. Sawyer, PhD

      Affiliations

    • From the Robert H. Hollis Laboratory of Environmental and Occupational Health, Division of Environmental and Occupational Health Sciences, Department of Medicine, National Jewish Medical and Research Center, Denver
  • ,
  • Roland M. du Bois, MD

      Affiliations

    • Clinical Genomic Group, Royal Brompton Hospital and National Heart Lung Institute, Imperial College of Science, Technology and Medicine, London
  • ,
  • Kenneth I. Welsh, PhD

      Affiliations

    • Clinical Genomic Group, Royal Brompton Hospital and National Heart Lung Institute, Imperial College of Science, Technology and Medicine, London
  • ,
  • Lisa A. Maier, MD, MSPH

      Affiliations

    • From the Robert H. Hollis Laboratory of Environmental and Occupational Health, Division of Environmental and Occupational Health Sciences, Department of Medicine, National Jewish Medical and Research Center, Denver
    • Department of Preventive Medicine and Biometrics
    • Division of Pulmonary and Critical Care Sciences, Department of Medicine, University of Colorado Health Sciences Center, Denver
    • Corresponding Author InformationReprint requests: Lisa A. Maier, MD, MSPH, National Jewish Medical and Research Center, 1400 Jackson St, Denver, CO 80206.

Received 9 August 2006; received in revised form 20 October 2006; accepted 23 October 2006. published online 08 January 2007.

Denver, Colo, and London, United Kingdom

Background

Beryllium stimulates TNF-α from chronic beryllium disease (CBD) bronchoalveolar lavage (BAL) cells.

Objective

We sought to relate TNF polymorphisms to beryllium-stimulated TNF-α production, to the development of CBD, and to the risk of more severe CBD over time.

Methods

We recruited 147 patients with CBD, 112 beryllium-sensitized subjects, and 323 control subjects; genotyped 5 TNF promoter polymorphisms; and measured beryllium-stimulated and unstimulated BAL cell TNF-α production from a subset of subjects.

Results

Beryllium-stimulated, but not beryllium-unstimulated, BAL cell TNF-α production was significantly increased in patients with CBD compared with that seen in those only sensitized (P = .0002). Those subjects with the TNF –857T allele and the only haplotype (haplotype 4) containing this allele demonstrated significantly lower unstimulated BAL cell TNF-α production compared with that seen in noncarriers (P = .009). Patients with CBD alone and combined with sensitized subjects carrying the TNF haplotype 1 compared with those without this haplotype had significantly increased beryllium-stimulated BAL cell TNF-α levels (P = .02). We found no significant association between patients with CBD, sensitized subjects, and control subjects with any of the TNF promoter polymorphisms or haplotypes. A greater decrease in Pao2 at maximum exercise was noted in patients with CBD with the −1031C allele (P = .03) and with haplotypes other than the TNF haplotype 1 (P = .01), 3 (from 5) of which contain the −1031C allele.

Conclusions

The −857T allele and haplotype 1 are associated with BAL cell TNF-α production, indicating a potential role of TNF promoter variants in regulation of TNF production in sensitized subjects and patients with CBD.

Clinical implications

TNF promoter variants are not risk factors for CBD or sensitization.

Key words: TNF-α, chronic beryllium disease, beryllium sensitization, berylliosis, genetics, polymorphism, bronchoalveolar lavage

Abbreviations used: BAL, Bronchoalveolar lavage, Be, Beryllium, BeLPT, Beryllium lymphocyte proliferation test, BeS, Beryllium sensitized, CBD, Chronic beryllium disease, NF, Nuclear factor, Pao2m, Pao2 at maximal exercise, SNP, Single nucleotide polymorphism

 

 Supported by P01 ES11810 and M01 RR00051 from the National Institutes of Health.Disclosure of potential conflict of interest: L. A. Maier has received grant support from Centocor and has served as an expert witness on behalf of her patients with CBD, for which she did not receive any direct compensation. The rest of the authors have declared that they have no conflict of interest.

PII: S0091-6749(06)02296-2

doi:10.1016/j.jaci.2006.10.028

The Journal of Allergy and Clinical Immunology
Volume 119, Issue 3 , Pages 687-696, March 2007